[TOP STORY] AfroCentric reports on half year to December
Loading player...
The owner of Medscheme is diversifying its portfolio with the likes of pharmaceuticals, virtual consultations and vaccine rollouts.
Other recent episodes
[TOP STORY] Staying ahead when the market plays by new rules
‘Instead of trying to be particularly right on something, I think it's more important to prepare for those different potential outcomes' – Sean Neethling, Head of Investments at Morningstar.
Warsh’s first FOMC: What it signals for the road ahead
Zimele Mbanjwa from FNB Wealth & Investments unpacks Absa's trading update. The stock looks cheap, but the market clearly didn't like what it saw. Ruen Naidu from Ninety One discusses what a new Fed chair with a hawkish stance and a structural reform agenda could mean for markets. Sean Neethling…
[TOP STORY] Benchmarks demystified: From market indices to personal portfolio goals
‘One of the biggest risks in choosing benchmarks is that you don't match what you actually want as an objective’ – Satrix Quantitative Portfolio Manager Siyabulela Nomoyi.
Prosus strategy for Tencent working
Independent analyst Jimmy Moyaha unpacks the Naspers and Prosus results as Takealot delivers an adjusted Ebitda profit – but is the story still all about Tencent? Invicta CEO Steven Joffe joins us to discuss results showing 50% of revenue now comes from offshore operations as tough local trading conditions persist…
[TOP STORY] Turning university research into real, impactful businesses right here in SA
The best opportunities which we fund are when there's cross-collaboration between faculties – and that's when you really get something unique. Wayne Stocks, Stocks & Strauss.